Friday, August 12, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

First patient-derived stem cell model developed for studying oculocutaneous albinism

by Medical Finance
in News
First patient-derived stem cell model developed for studying oculocutaneous albinism
9
SHARES
105
VIEWS
Share on FacebookShare on Twitter

Researchers at the National Eye Institute (NEI) have developed the first patient-derived stem cell model for studying eye conditions related to oculocutaneous albinism (OCA). The model’s development is described in the January issue of the journal Stem Cell Reports. NEI is part of the National Institutes of Health.

This ‘disease-in-a-dish’ system will help us understand how the absence of pigment in albinism leads to abnormal development of the retina, optic nerve fibers, and other eye structures crucial for central vision.”


Aman George, Ph.D., staff scientist, NEI Ophthalmic Genetics and Visual Function Branch, and lead author of the report

OCA is a set of genetic conditions that affects pigmentation in the eye, skin, and hair due to mutation in the genes crucial to melanin pigment production. In the eye, pigment is present in the retinal pigment epithelium (RPE), and aids vision by preventing the scattering of light. The RPE is located right next to the eye’s light-sensing photoreceptors and provides them nourishment and support. People with OCA lack pigmented RPE and have an underdeveloped fovea, an area within the retina that is crucial for central vision. The optic nerve carries visual signals to the brain.

People with OCA have misrouted optic nerve fibers. Scientists think that RPE plays a role in forming these structures and want to understand how lack of pigment affects their development.

“Animals used to study albinism are less than ideal because they lack foveae,” said Brian P. Brooks, M.D., Ph.D., NEI clinical director and chief of the Ophthalmic Genetics and Visual Function Branch. “A human stem cell model that mimics the disease is an important step forward in understanding albinism and testing potential therapies to treat it.”

Human iPSC derived RPE monolayer on top of the membrane in a trans-well culture system. Unaffected RPE cells (CTRL1 and 2) exhibiting pigmentation and OCA1A and OCA2 RPE from albinism patients exhibiting pigmentation defects.

To make the model, researchers reprogrammed skin cells from individuals without OCA and people with the two most common types of OCA (OCA1A and OCA2) into pluripotent stem cells (iPSCs). The iPSCs were then differentiated to RPE cells. The RPE cells from OCA patients were identical to RPE cells from unaffected individuals but displayed significantly reduced pigmentation.

The researchers will use the model to study how lack of pigmentation affects RPE physiology and function. In theory, if fovea development is dependent on RPE pigmentation, and pigmentation can be somehow improved, vision defects associated with abnormal fovea development could be at least partially resolved, according to Brooks.

“Treating albinism at a very young age, perhaps even prenatally, when the eye’s structures are forming, would have the greatest chance of rescuing vision,” said Brooks. “In adults, benefits might be limited to improvements in photosensitivity, for example, but children may see more dramatic effects.”

The team is now exploring how to use their model for high-throughput screening of potential OCA therapies.

Source:

National Institutes of Health

Journal reference:

George, A., et al. (2022) In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium. Stem Cell Reports. doi.org/10.1016/j.stemcr.2021.11.016.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

ANU researchers identify why Th17 cells go rogue and promote the onset of multiple sclerosis

Genetically engineered kidney organoids solve mystery of a rare disease

by Medical Finance
August 12, 2022
0

Researchers have solved a medical mystery in a poorly understood disease by uncovering which cells cause tumors in patients with...

UW and Stanford researchers complete study on the link between food environment and dietary health

Complex molecular dance could inform the development of future treatments for fragile X syndrome

by Medical Finance
August 12, 2022
0

Like many neurological diseases, there's a lot we don't understand about fragile X syndrome. But, after studying the disorder for...

Nutritional components hold promise for improving the health and well-being of adults

Older heart muscle cells accumulate new genetic mutations -; while losing the ability to repair them

by Medical Finance
August 12, 2022
0

Why does the risk of heart disease go up as we age? Known risk factors such as hypertension or high...

New mathematical model can calculate the risk of resistance evolution for drug pairs

Investigating the prerequisites for developing RNA-based antibiotics

by Medical Finance
August 12, 2022
0

In the fight against the Covid-19 pandemic, mRNA-based vaccines have impressively demonstrated their potential. Using this technology, scientists were able...

Rapid DNA sequencing technique used to diagnose rare genetic disease in short time

Mount Sinai and Regeneron Genetics Center launch a new human genome sequencing research project

by Medical Finance
August 12, 2022
0

Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing...

Study: Nano-vectors for CRISPR/Cas9-mediated genome editing. Image Credit: Meletios Verras/Shutterstock

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

by Medical Finance
August 12, 2022
0

In a recent study published in the journal Nano Today, researchers reviewed non-viral nano-vectors used for delivering the clustered regularly interspaced...

Next Post
Study: COPD and social distancing in the UK. Image Credit: Stock-Asso/Shutterstock

COPD patients more compliant with COVID-19 restrictions in the UK

Study: CCBYNC Open access Research Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. Image Credit: Yuganov Konstantin/Shutterstock

Hazards of persistent and new clinical sequelae caused by SARS-CoV-2 infection among elderly patients

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: SARS-CoV-2 IgG seroprevalence in the Okinawa Main Island and remote islands in Okinawa, Japan, 2020-2021. Image Credit: MTX-design / Shutterstock.com
    Evaluating SARS-CoV-2 IgG seroprevalence in the Okinawa islands of Japan
  • Study: Sex disparities in COVID-19 outcomes in the United States: Quantifying and contextualizing variation. Image Credit: elenabsl/Shutterstock
    Researchers explore sex disparities in COVID-19 outcomes
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply